Novartis (NYSE:NVS) Should Be Bought On A Pullback. Entresto & Cosentyx drugs really have the ability to drive sales forward.
Subscribe For Mentoring
Categories
- Allergan
- Amazon
- American Express
- AmerisourceBergen
- Anheuser Busch Inbev
- Apple
- Biotech
- Brinker
- British American Tobacco
- Campbell
- Cardinal Health
- Carlisle
- Caterpillar
- Chevron
- Chipotle
- Cisco
- Costco
- Disney
- Duke Energy
- Embraer
- EMR
- Enbridge
- Express Scripts
- Federated Investors
- First Solar
- Ford
- Franklin Resources
- GE
- Gilead
- Gold
- Hawaiian Holdings
- Hormel Foods
- Hyatt Hotels
- IBM
- Income
- Juniper
- Kroger
- L Brands
- MCD
- MSFT
- Nat Gas
- Nike
- Novartis
- Nvidia
- Oil
- orcl
- Pfizer
- Procter & Gamble
- RBC
- Recommendations
- Sanderson Farms
- Silver
- Spectra Energy
- spx
- SPY
- Stericycle
- Stock Picks
- Target
- Trading
- Uncategorized
- US Dollar
- Walmart
Archives
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- May 2016
- April 2016
- July 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
-
Recent Posts
Recent Comments
Meta
Newsletter